Moderna and Merck announce data from melanoma combination therapy study
Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths
Read More
Section: Research
smartbax licenses compound from Aicuris for next-generation antibiotic development
The new programme addresses the urgent unmet medical need for new therapies to tackle antibiotic-resistant infections
Read More
DEBRA Research and University Medical Center Groningen launch clinical trial site for epidermolysis bullosa
This rare genetic disorder causes skin to become extremely fragile
Read More
Takeda’s zasocitinib demonstrates positive results in plaque psoriasis
Around 64 million people worldwide live with psoriasis
Read More
Pfizer’s Braftovi combination therapy shows positive results for colorectal cancer
Colorectal cancer is the third most common cancer globally, with approximately 1.8 million people diagnosed in 2022
Read More